Erasca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Erasca and other ETFs, options, and stocks.

About ERAS

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

CEO

Jonathan E. Lim

CEOJonathan E. Lim

Employees

103

Employees103

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2018

Founded2018

Employees

103

Employees103

ERAS Key Statistics

Market cap

361.19M

Market cap361.19M

Price-Earnings ratio

-2.05

Price-Earnings ratio-2.05

Dividend yield

—

Dividend yield—

Average volume

1.37M

Average volume1.37M

High today

$1.30

High today$1.30

Low today

$1.18

Low today$1.18

Open price

$1.22

Open price$1.22

Volume

700.90K

Volume700.90K

52 Week high

$3.45

52 Week high$3.45

52 Week low

$1.01

52 Week low$1.01

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ERAS. This list is generated using Robinhood data, and it’s not a recommendation.

Erasca

Why Robinhood?

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Show more

ERAS Key Statistics

Analyst ratings

100%

People also own

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.